These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12606537)

  • 1. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians.
    Muller YL; Bogardus C; Pedersen O; Baier L
    Diabetes; 2003 Mar; 52(3):895-8. PubMed ID: 12606537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects.
    Fanelli M; Filippi E; Sentinelli F; Romeo S; Fallarino M; Buzzetti R; Leonetti F; Baroni MG
    Dis Markers; 2005; 21(4):175-80. PubMed ID: 16403952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome.
    Ambye L; Rasmussen S; Fenger M; Jørgensen T; Borch-Johnsen K; Madsbad S; Urhammer SA
    Diabetes Res Clin Pract; 2005 Feb; 67(2):175-9. PubMed ID: 15649578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians.
    Muller YL; Bogardus C; Beamer BA; Shuldiner AR; Baier LJ
    Diabetes; 2003 Jul; 52(7):1864-71. PubMed ID: 12829658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity.
    Stefan N; Kovacs P; Stumvoll M; Hanson RL; Lehn-Stefan A; Permana PA; Baier LJ; Tataranni PA; Silver K; Bogardus C
    Diabetes; 2003 Jun; 52(6):1544-50. PubMed ID: 12765968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations.
    Stumvoll M; Fritsche A; t'Hart LM; Machann J; Thamer C; Tschritter O; Van Haeften TW; Jacob S; Dekker JM; Maassen JA; Machicao F; Schick F; Heine RJ; Häring H
    Exp Clin Endocrinol Diabetes; 2004 May; 112(5):253-7. PubMed ID: 15146371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is associated with type 2 diabetes in Tunisian population.
    Jemaa Z; Kallel A; Sleimi C; Mahjoubi I; Feki M; Ftouhi B; Slimane H; Jemaa R; Kaabachi N
    Diabetes Metab Syndr; 2015; 9(4):316-9. PubMed ID: 25470625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.
    Ek J; Andersen G; Urhammer SA; Gaede PH; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O
    Diabetologia; 2001 Dec; 44(12):2220-6. PubMed ID: 11793024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gly482Ser polymorphism of the coactivator-1alpha of the activated receptor of peroxisome gamma proliferation in individuals from Maracaibo, Venezuela].
    Zambrano M; Fernández E; López M; Rangel A; de Romero P; Fernández V; Marina Morales L; Molero-Conejo E; Connell L; Raleigh X; Aranguren-Mendez J
    Invest Clin; 2009 Sep; 50(3):285-94. PubMed ID: 19961051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser polymorphisms on rosiglitazone response in Chinese patients with type 2 diabetes mellitus.
    Zhang KH; Huang Q; Dai XP; Yin JY; Zhang W; Zhou G; Zhou HH; Liu ZQ
    J Clin Pharmacol; 2010 Sep; 50(9):1022-30. PubMed ID: 20498286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGC-1alpha Gly482Ser polymorphism is associated with the plasma adiponectin level in type 2 diabetic men.
    Okauchi Y; Iwahashi H; Okita K; Yuan M; Matsuda M; Tanaka T; Miyagawa J; Funahashi T; Horikawa Y; Shimomura I; Yamagata K
    Endocr J; 2008 Dec; 55(6):991-7. PubMed ID: 18614852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism.
    Vandenbeek R; Khan NP; Estall JL
    Endocrinology; 2018 Feb; 159(2):853-865. PubMed ID: 29186342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.
    Barroso I; Luan J; Sandhu MS; Franks PW; Crowley V; Schafer AJ; O'Rahilly S; Wareham NJ
    Diabetologia; 2006 Mar; 49(3):501-5. PubMed ID: 16435105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gly482Ser polymorphism in the peroxisome proliferator-activated receptor gamma coactivator-1alpha gene is associated with oxidative stress and abdominal obesity.
    Weng SW; Lin TK; Wang PW; Chen IY; Lee HC; Chen SD; Chuang YC; Liou CW
    Metabolism; 2010 Apr; 59(4):581-6. PubMed ID: 19913841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter.
    Choi YS; Hong JM; Lim S; Ko KS; Pak YK
    Biochem Biophys Res Commun; 2006 Jun; 344(3):708-12. PubMed ID: 16631115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not.
    Petrovic MG; Kunej T; Peterlin B; Dovc P; Petrovic D
    Diabetes Metab Res Rev; 2005; 21(5):470-4. PubMed ID: 15782399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.
    Nair S; Lee YH; Lindsay RS; Walker BR; Tataranni PA; Bogardus C; Baier LJ; Permana PA
    Diabetologia; 2004 Jun; 47(6):1088-95. PubMed ID: 15156315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the lamin A/C gene as a candidate for type II diabetes susceptibility in Pima Indians.
    Wolford JK; Hanson RL; Bogardus C; Prochazka M
    Diabetologia; 2001 Jun; 44(6):779-82. PubMed ID: 11440372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians.
    Kunej T; Globocnik Petrovic M; Dovc P; Peterlin B; Petrovic D
    Folia Biol (Praha); 2004; 50(5):157-8. PubMed ID: 15581067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Andrulionyte L; Peltola P; Chiasson JL; Laakso M;
    Diabetes; 2006 Jul; 55(7):2148-52. PubMed ID: 16804087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.